What is the Accelerating Access Initiative?
The Accelerating Access Initiative is a cooperative endeavor of seven research-based pharmaceutical companies including Boehringer Ingelheim, UN agencies and the World Bank. The initiative started in 2000 and by June 2006, the treatments delivered by the Accelerating Access Initiative in developing countries were reaching more than 750,000 patients. The participants of the initiative are committed to working with governments, international organisations and other stakeholders to find ways to broaden access while ensuring rational, effordable, safe and effective use of drugs for HIV/AIDS-related illnesses.
